source
- U.S. experts to evaluate if measles elimination status still holds amid rising casesNoel T. Brewer, chair of the U.S. National Verification Committee, explains that his group will review the CDC’s annual measles report to decide if the United States continues to meet elimination c…
- Third time’s the charm for Replimune as melanoma drug earns FDA greenlightReplimune’s immunotherapy for advanced melanoma faced a perilous regulatory road with two previous rejections, but the drug—to be marketed as Tudriqev—prevailed with strong support from oncologists…BioSpace · 46m ago↗ source
- Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M